Wellington Shields Capital Management’s Biogen BIIB Stock Holding History

Wellington Shields Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,652	Closed	-$383K	–	314
2024 Q2	$383K	Hold	1,652	–	–	0.07%	177
2024 Q1	$356K	Hold	1,652	–	–	0.07%	184
2023 Q4	$427K	Hold	1,652	–	–	0.05%	161
2023 Q3	$425K	Sell	1,652 -152	-8%	-$40.7K	0.06%	151
2023 Q2	$514K	Hold	1,804	–	–	0.06%	145
2023 Q1	$502K	Hold	1,804	–	–	0.06%	146
2022 Q4	$500K	Hold	1,804	–	–	0.06%	146
2022 Q3	$482K	Hold	1,804	–	–	0.11%	141
2022 Q2	$368K	Hold	1,804	–	–	0.05%	177
2022 Q1	$380K	Hold	1,804	–	–	0.04%	200
2021 Q4	$433K	Hold	1,804	–	–	0.06%	224
2021 Q3	$511K	Sell	1,804 -1,500	-45%	-$492K	0.07%	174
2021 Q2	$1.14M	Hold	3,304	–	–	0.14%	125
2021 Q1	$924K	Hold	3,304	–	–	0.09%	153
2020 Q4	$809K	Sell	3,304 -27	-0.8%	-$6.96K	0.11%	146
2020 Q3	$945K	Hold	3,331	–	–	0.15%	106
2020 Q2	$891K	Hold	3,331	–	–	0.14%	115
2020 Q1	$1.05M	Sell	3,331 -700	-17%	-$212K	0.2%	94
2019 Q4	$1.2M	Sell	4,031 -215	-5%	-$59.7K	0.18%	107
2019 Q3	$989K	Hold	4,246	–	–	0.16%	116
2019 Q2	$993K	Hold	4,246	–	–	0.16%	114
2019 Q1	$1M	Hold	4,246	–	–	0.17%	114
2018 Q4	$1.28M	Hold	4,246	–	–	0.24%	90
2018 Q3	$1.5M	Hold	4,246	–	–	0.24%	101
2018 Q2	$1.23M	Hold	4,246	–	–	0.2%	113
2018 Q1	$1.16M	Hold	4,246	–	–	0.18%	125
2017 Q4	$1.35M	Buy	4,246 +27	+0.6%	+$8.66K	0.21%	101
2017 Q3	$1.32M	Hold	4,219	–	–	0.22%	104
2017 Q2	$1.15M	Hold	4,219	–	–	0.19%	123
2017 Q1	$1.15M	Hold	4,219	–	–	0.19%	121
2016 Q4	$1.2M	Hold	4,219	–	–	0.2%	106
2016 Q3	$1.32M	Hold	4,219	–	–	0.23%	104
2016 Q2	$1.02M	Hold	4,219	–	–	0.17%	116
2016 Q1	$1.1M	Hold	4,219	–	–	0.19%	109
2015 Q4	$1.29M	Hold	4,219	–	–	0.22%	84
2015 Q3	$1.23M	Hold	4,219	–	–	0.21%	90
2015 Q2	$1.7M	Hold	4,219	–	–	0.26%	79
2015 Q1	$1.78M	Hold	4,219	–	–	0.27%	75
2014 Q4	$1.43M	Sell	4,219 -300	-7%	-$97.1K	0.23%	91
2014 Q3	$1.5M	Hold	4,519	–	–	0.25%	85
2014 Q2	$1.43M	Hold	4,519	–	–	0.22%	91
2014 Q1	$1.38M	Hold	4,519	–	–	0.24%	82
2013 Q4	$1.26M	Hold	4,519	–	–	0.23%	84
2013 Q3	$1.09M	Hold	4,519	–	–	0.21%	102
2013 Q2	$972K	Buy	+4,519	New	+$966K	0.17%	122

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Shields Capital Management's BIIB Position: Q3 2024 in Review

Wellington Shields Capital Management sold out of Biogen (BIIB) in Q3 2024, closing a stake of 1,652 shares — an estimated $383K sold.

Wellington Shields Capital Management first reported a position in BIIB in Q2 2013 and held it in 45 quarters. The position peaked at $1.78M in Q1 2015. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

Wellington Shields Capital Management reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
Wellington Shields Capital Management sold 1,652 Biogen shares in Q3 2024, an estimated $383K.
Wellington Shields Capital Management first reported a position in Biogen in Q2 2013 and held it in 45 quarters.
Wellington Shields Capital Management's Biogen position peaked at $1.78M in Q1 2015.
917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Wellington Shields Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.